Moxifloxacin Labatec, collyre en solution
7680664900026
CH-66490
Augentropfen
Associated product:
MOXIFLOXACIN Labatec gtt opht 5.45 mg 5 ml
1 / 2
google
Article details
- Package size
- 5
- Selling units
- 5
- Measure
- ml
- Galenic form
- Augentropfen
- Galenic group
- Augenmittel
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
moxifloxacinum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
moxifloxacini hydrochloridum
|
5.45 MG | Substance | WIZUS |
|
acidum boricum
|
- | Substance | HIMDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 66490
- Drug name
- Moxifloxacin Labatec, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01AE07
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 05/10/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 11.07.1.
- Domain
- Human medicine
Package details
- Description (FR)
- MOXIFLOXACIN Labatec gtt opht 5.45 mg 5 ml
- Description (DE)
- MOXIFLOXACIN Labatec Trp Opht 5.45 mg 5 ml
- Market launch
- 15/12/2025
- Narcotic (BTM)
- No
Other package sizes (1)
MOXIFLOXACIN Labatec gtt opht 5 mg/ml fl 5 ml
None None
GTIN: 7680664900019